Skip to main content
logo
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
1.430
+0.010 (0.70%)
At close: Nov 9, 2026, 4:00 PM EST
1.440
+0.010 (0.71%)
Pre-market: Nov 10, 2026, 7:18 AM EST

CervoMed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.014.019.747.14--
Revenue Growth
-99.86%-58.86%36.29%---
Gross Profit
-21.8-17.81-9.06-1.29-1.34-
Operating Income
-29.23-28.29-18.23-7.81-3.48-5.04
Net Income
-28.52-26.97-16.29-2.17-5.8-4.14
Earnings Per Share
-2.60-2.98-2.02-0.82-11.20-0.92
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
19.620.8638.927.794.096.67
Total Debt
----12.4110.03
Net Cash (Debt)
19.620.8638.927.79-8.32-3.36
Net Cash Growth
-28.20%-46.39%399.46%---
Net Cash Per Share
1.782.314.822.93-16.06-0.75

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.59-23.45-16.53-7.45-2.57-4.13
Free Cash Flow
-26.59-23.45-16.53-7.45-2.57-4.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---93.04%-18.11%--
Operating Margin
-334924.87%-706.22%-187.18%-109.35%--
Pretax Margin
-326822.54%-673.06%-167.29%-30.40%--
Profit Margin
-326822.54%-673.06%-167.29%-30.40%--

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2479.2418.241.986.06--